SPRR2F | Small proline-rich protein 2F | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
C4BPB | Complement component 4 binding protein, beta | Plasma proteins Predicted secreted proteins
| ![](/images/51620/ihc_selected_60x60.jpg) | ![](/images/51620/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/51620/119346_B_8_1_rna_selected_60x60.jpg) | Group enriched |
ECEL1 | Endothelin converting enzyme-like 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | Predicted intracellular proteins Predicted secreted proteins
| ![](/images/10953/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/11561/ihc_cell_selected_60x60.jpg) | ![](/images/11561/28476_A_3_6_rna_selected_60x60.jpg) | Tissue enriched |
KLHDC8A | Kelch domain containing 8A | Predicted intracellular proteins
| ![](/images/30181/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30181/65645_B_9_8_rna_selected_60x60.jpg) | Tissue enriched |
MAG | Myelin associated glycoprotein | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9345/26618_A_4_4_rna_selected_60x60.jpg) | Group enriched |
NXPH2 | Neurexophilin 2 | Predicted secreted proteins
| ![](/images/34759/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34759/153462_B_8_2_rna_selected_60x60.jpg) | Group enriched |
PROK1 | Prokineticin 1 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images/30085/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
FSHR | Follicle stimulating hormone receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
LRRTM3 | Leucine rich repeat transmembrane neuronal 3 | Predicted membrane proteins
| ![](/images/24109/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24109/52003_B_8_6_rna_selected_60x60.jpg) | Group enriched |
ANGPTL5 | Angiopoietin-like 5 | Predicted secreted proteins
| ![](/images/38516/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38516/80532_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
CRYGD | Crystallin, gamma D | Disease related genes Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
FOXL2 | Forkhead box L2 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/69613/155971_B_8_6_rna_selected_60x60.jpg) | Group enriched |
HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/18073/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18073/40860_B_8_1_rna_selected_60x60.jpg) | Group enriched |
MUM1L1 | Melanoma associated antigen (mutated) 1-like 1 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20464/132003_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
SPOCK3 | Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 | Predicted intracellular proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
FRRS1L | Ferric-chelate reductase 1-like | Predicted membrane proteins
| ![](/images/23481/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/23481/ihc_cell_selected_60x60.jpg) | ![](/images/23481/50498_B_2_3_rna_selected_60x60.jpg) | Group enriched |
MTUS2 | Microtubule associated tumor suppressor candidate 2 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31475/67454_B_9_1_rna_selected_60x60.jpg) | Group enriched |
SGCZ | Sarcoglycan, zeta | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| ![](/images/17585/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17585/40732_B_9_2_rna_selected_60x60.jpg) | Group enriched |
SIGLEC11 | Sialic acid binding Ig-like lectin 11 | Plasma proteins Predicted membrane proteins
| ![](/images/60278/135810_A_1_7_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60278/135811_B_9_8_rna_selected_60x60.jpg) | Group enriched |
ANO4 | Anoctamin 4 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/53412/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/53412/128639_A_2_7_rna_selected_60x60.jpg) | Group enriched |
ARX | Aristaless related homeobox | Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
FHL2 | Four and a half LIM domains 2 | Predicted intracellular proteins
| | | | ![](/images/6028/18426_B_8_8_rna_selected_60x60.jpg) | Group enriched |
FOXL2NB | FOXL2 neighbor | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images/68671/1352_D10_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
GPR88 | G protein-coupled receptor 88 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/7488/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7488/108509_B_9_5_rna_selected_60x60.jpg) | Group enriched |
LHX9 | LIM homeobox 9 | Predicted intracellular proteins Transcription factors
| ![](/images/9695/ihc_selected_60x60.jpg) | ![](/images/9695/1446_C4_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/9695/25109_B_8_1_rna_selected_60x60.jpg) | Group enriched |
NR5A1 | Nuclear receptor subfamily 5, group A, member 1 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
PPP4R4 | Protein phosphatase 4, regulatory subunit 4 | Predicted intracellular proteins
| ![](/images/50321/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/50321/144353_B_9_5_rna_selected_60x60.jpg) | Group enriched |
ZIM2 | Zinc finger, imprinted 2 | Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images/71856/1418_E3_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
KCNT1 | Potassium channel, subfamily T, member 1 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/59880/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/59880/ihc_cell_selected_60x60.jpg) | ![](/images/59880/139510_B_9_3_rna_selected_60x60.jpg) | Group enriched |
RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Transporters
| ![](/images/48489/ihc_selected_60x60.jpg) | ![](/images/42726/1293_B9_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/48489/114605_B_9_2_rna_selected_60x60.jpg) | Group enriched |
ABCA10 | ATP-binding cassette, sub-family A (ABC1), member 10 | Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/14535/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14535/43340_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | Predicted membrane proteins Transporters
| ![](/images/54823/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54823/128584_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | Enzymes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | Cancer-related genes Enzymes Predicted secreted proteins
| ![](/images/25996/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/25996/58748_B_4_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADRB3 | Adrenoceptor beta 3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
AJAP1 | Adherens junctions associated protein 1 | Predicted membrane proteins
| ![](/images/12157/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12157/30431_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
AMHR2 | Anti-Mullerian hormone receptor, type II | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ANGPT4 | Angiopoietin 4 | Predicted secreted proteins RAS pathway related proteins
| ![](/images/13260/ihc_selected_60x60.jpg) | ![](/images/13305/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13260/28493_B_3_6_rna_selected_60x60.jpg) | Tissue enhanced |
AP000350.10 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000400325} | Predicted membrane proteins
| ![](/images/42960/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42960/115453_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
ART5 | ADP-ribosyltransferase 5 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| ![](/images/44099/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44099/106702_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ASIP | Agouti signaling protein | Predicted secreted proteins
| ![](/images/48636/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/48636/ihc_cell_selected_60x60.jpg) | ![](/images/48636/110199_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
ASXL3 | Additional sex combs like transcriptional regulator 3 | Disease related genes Predicted intracellular proteins
| ![](/images/40034/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40034/120256_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
B4GALNT4 | Beta-1,4-N-acetyl-galactosaminyl transferase 4 | Enzymes Predicted secreted proteins
| ![](/images/53126/ihc_selected_60x60.jpg) | ![](/images/53126/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53126/119890_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
BAMBI | BMP and activin membrane-bound inhibitor | Plasma proteins Predicted membrane proteins
| ![](/images/10866/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10866/62928_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
BNC2 | Basonuclin 2 | Predicted intracellular proteins Transcription factors
| ![](/images/18525/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/18525/42232_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
BRS3 | Bombesin-like receptor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images/3626/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3626/10880_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
C21orf62 | Chromosome 21 open reading frame 62 | Predicted intracellular proteins Predicted secreted proteins
| ![](/images/34173/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/16899/ihc_cell_selected_60x60.jpg) | ![](/images/34173/64972_B_5_5_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1H | Calcium channel, voltage-dependent, T type, alpha 1H subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/39125/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39125/91318_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CAMK1G | Calcium/calmodulin-dependent protein kinase IG | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |